TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: Center of pressure velocity timing
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Center of pressure velocity magnitude
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Modified Socket Comfort Score (Comfort)
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Modified Socket Comfort Score (Smoothness)
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Participant wedge preference
Endpoint domain: Life impact
Endpoint subdomain: Personal circumstances
Primary endpoint: T Cell Counts
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Pulmonary embolism incidence
Endpoint domain: Mortality/survival
Primary endpoint: Progression of Coronary Artery Calcium
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Trait Anxiety Scale (TAS)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Gadolinium-enhancing lesion number change
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neurological outcomes
Primary endpoint: Change of pressure in femoral intramedullary canal
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Eradication Rates
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Number of subjects with treatment-related intolerance
Endpoint domain: Adverse events/effects
Primary endpoint: WOMAC Score Change
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Clinical Response of Success
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: fixation survival
Endpoint domain: Mortality/survival
Primary endpoint: composite end-point combining overall and fixation survival
Endpoint domain: Mortality/survival
Primary endpoint: Non-fatal stroke
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Proportion of patients without events
Endpoint domain: Mortality/survival
Primary endpoint: time until full sustainable return-to-work (RTW)
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: Total number of sickness absence days
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Depression on the Hamilton Depression Rating Scale
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: All adverse events
Endpoint domain: Adverse events/effects
Primary endpoint: All serious adverse events
Endpoint domain: Adverse events/effects
Primary endpoint: Change in acceptable types of female circumcision
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Change in types of female circumcision participants would perform
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Change in proportion of participants opposing female circumcision
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Changes in viral load (HIV-RNA)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Changes in CD4 cell count
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Incidence of delirium after cardiac surgery
Endpoint domain: Adverse events/effects
Primary endpoint: nasopharyngeal pH
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Whole Blood Biomarker Results
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Ejection fraction %
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Patient satisfaction with the control of cancer-related pain
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: lamellar body count
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Doppler data of main pulmonary artery and right pulmonary artery
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: mitral valve e/a wave ratio
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: birth of healthy child
Endpoint domain: Mortality/survival
Primary endpoint: BBN skills
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Grade of sialadenitis
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Jail Recidivism
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: Mental Health Service Utilization
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Change in the percentage of donor specific antibodies
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Changes in the percentage of blood immunologic markers
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Percent Compliance
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: event rate of cardiac death within 12 months
Endpoint domain: Mortality/survival
Primary endpoint: Medical stabilization
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Peak Oxygen Consumption
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Alzheimer's Disease Assessment Scale cognitive part (ADAScog)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Level of stress and control at work
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Percentage of subjects with complete closure of the study ulcer
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion of product related Adverse Events (AEs), Serious Adverse Events (SAEs), and Unanticipated Adverse Events
Endpoint domain: Adverse events/effects
Primary endpoint: oncologic results
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Defervesce rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Real-time conscious motor processing propensity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Functional balance and gait ability
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change From Baseline in Mean St.George's Respiratory Questionnaire (SGRQ) Total Score
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Impairment in the Affected Upper Extremity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in transversus abdominis muscle thickness
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: WOMAC Change
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: VAS Change
Endpoint domain: Life impact
Endpoint subdomain: Pain
Primary endpoint: Intelligence quotient of offspring
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Percentage of time spent with glucose levels between 70-140 mg/dl
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Total inpatient discharges
Endpoint domain: Resource use
Endpoint subdomain: Hospital
Primary endpoint: Total inpatient days
Endpoint domain: Resource use
Endpoint subdomain: Hospital
Primary endpoint: Total number of emergency department visits
Endpoint domain: Resource use
Endpoint subdomain: Hospital
Primary endpoint: patients' self-reported satisfaction with the treatment
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: PD20 methacholine change
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: accuracy of Cyranose in discriminating between patient groups
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Incidence of delayed graft function
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Overall Bowel Symptom Scores (BSS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: MRI signals predictive of treatment response
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Unstimulated Salivary Flow Rate (USFR)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Clinical Global Impression Change (CGI-C)
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Number of patients with Acute Coronary Syndrome and Chronic Obstructive Pulmonary Disease
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Microvascular reactivity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Macrovascular reactivity - FMD of brachial artery
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Oxidative stress - thiobarbituric acid reactive substances (TBARS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Overall Mean Scores of Gum Comfort Questionnaire
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Relative sensitivity of dermatologists
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in adverse event records
Endpoint domain: Adverse events/effects
Primary endpoint: Change in clinical chemistry (CD4, CD8, HIV-1 RNA)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Change in hematology laboratory elevations
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: FEV1 AUC0-12h
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Symptom severity measured by Beck Depression Inventory
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Diagnostic performance of nonlinear elasticity parameter
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Diagnostic performance of elasticity heterogeneity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Recurrence of cholesteatoma
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Residual cholesteatoma
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Change in Weiss Functional Impairment Rating Scale (WFIRS-P)
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: NEI VFQ 25 quality of life score change
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Number of Participants Experiencing Hypoxia
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: prevalence of sleep-disordered breathing
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: proportion of patients who use auto-CPAP >4 hours per night
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Endoxifen Concentrations
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reward sensitivity
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Effort sensitivity
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Rate of adherence to PrEP with TDF/FTC
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Percentage of patients gaining ≥ 50% pain reduction
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Changes of lung diffusing capacity for nitric oxide (DLNO)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Outcomes after Laparoscopic Nissen
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: music perception skills
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: keratinized tissue width
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Intraoperative and postoperative pain assessment
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Intestinal Microbiome (Bacteria) - Richness
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Intestinal Microbiome (Bacteria) - Shannon index
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Diet - diet quality score
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: resting-state functional Magnetic Resonance Imaging
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Cell proliferation of AT-MSCs
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Differentiation potential of AT-MSCs to adipocyte
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Differentiation potential of AT-MSCs to osteoblast
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percentage of subjects with anti-PRP antibody concentrations ≥1µg/ml
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Percentage of subjects with SBA-MenC titers ≥ 128
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Change from baseline % flow-mediated dilation (%FMD)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Lysholm Knee Scoring Scale
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Maximum Observed Plasma Concentration (Cmax) of Total Alectinib
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cmax of Unbound Alectinib
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Area Under the Plasma Concentration-Time Curve From Time 0 Extrapolated to Infinity (AUC 0-inf) for Total Alectinib
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion of Successfully Re-fitted Subjects
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Hours of PAP usage (>4 hours)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percent days of PAP use
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of Participants With Grade 3, 4, and 5 Treatment Related Adverse Events
Endpoint domain: Adverse events/effects
Primary endpoint: Incidence of anastomotic stricture
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: placebo-adjusted weight loss of ≥3.0% from baseline to Visit 14
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: weight loss of >5.0% in at least 35% of prediabetic subjects or in at least 25% of diabetic subjects
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Presence of dyspnea
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: cRP levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: d-dimer levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: CD4/CD8 Ratio
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: ventilatory functions
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean Change in Endothelial Function
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Safety of Intervention
Endpoint domain: Adverse events/effects
Primary endpoint: visit and intervention adherence
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Early Virologic Response
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Rate of disease remission
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Rate of entering the critical stage
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Time of entering the critical stage
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in receipt of primary care services - self report
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Change in receipt of primary care services - EMR review
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Steroid-free clinical response
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of pain free days after 3 months
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Change in limits of stability parameter
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of Unacceptable Toxicity (UT) Events
Endpoint domain: Adverse events/effects
Primary endpoint: Number of Subjects Who Achieved cCR or pCR
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: AFib or AFl occurrence
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Relief of epiphora
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Intraoperative and postoperative Opiate consumption
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Cocaine Use as Assessed by Proportion of Visits With Cocaine-negative Urine Drug Screen
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: PK/PD parameters
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Postoperative surgical complications
Endpoint domain: Adverse events/effects
Primary endpoint: Change in Perceived Safety Benefit of Booster Seats
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Change in Key Benefit of Booster Seats
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Frequency of Hernia Recurrence
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Change in SPEED questionnaire score
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Change in grading of lashes contamination
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Complete ear pain relief
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Performance and accuracy of glucose levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Performance and accuracy of pO2
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Performance and accuracy of heart rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Lower insulin incremental area under the curve (iAUC)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Number of Participants With Local and Systemic Reactogenicity Signs and Symptoms
Endpoint domain: Adverse events/effects
Primary endpoint: Number of Participants With Related Adverse Events
Endpoint domain: Adverse events/effects
Primary endpoint: Number of Participants With Sustained Decrease in CD4 Count and CD4%
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Percentage of Patients Alive and Free of Progression at 12 Weeks
Endpoint domain: Mortality/survival
Primary endpoint: Healing of the Ulcer
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Usefulness of patient education information
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Average echocardiography charges
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Clinician's Interview Based Impression of Change-Plus Caregiver Input (CIBIC-Plus)
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Magnetoencephalography (MEG) activation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Percentage of successful achievement of therapeutic level
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Urinary NTX
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Change in Serum Potassium
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Number of Participants With Positive Anti-Recombinant Human Heparan N-Sulfatase (rhHNS) Antibody Status in Serum
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Area Under Curve (AUC) of Recombinant Human Heparan N-Sulfatase (rhHNS) Concentration in Cerebro Spinal Fluid (CSF)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Change in number of hypoglycaemic events from baseline
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: fMRI signal increases
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Macular hole progression
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Femoral offset
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Leg length difference
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Wiberg angle
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Lack of tumor emboli
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Hamilton Psychiatric Rating Scale for Depression (HRSD-24)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in index symptom(s)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes